These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Using Polygenic Hazard Scores to Predict Age at Onset of Alzheimer's Disease in Nordic Populations. Motazedi E; Cheng W; Thomassen JQ; Frei O; Rongve A; Athanasiu L; Bahrami S; Shadrin A; Ulstein I; Stordal E; Brækhus A; Saltvedt I; Sando SB; O'Connell KS; Hindley G; van der Meer D; Bergh S; Nordestgaard BG; Tybjærg-Hansen A; Bråthen G; Pihlstrøm L; Djurovic S; Frikke-Schmidt R; Fladby T; Aarsland D; Selbæk G; Seibert TM; Dale AM; Fan CC; Andreassen OA J Alzheimers Dis; 2022; 88(4):1533-1544. PubMed ID: 35848024 [TBL] [Abstract][Full Text] [Related]
8. Polygenic hazard scores in preclinical Alzheimer disease. Tan CH; Hyman BT; Tan JJX; Hess CP; Dillon WP; Schellenberg GD; Besser LM; Kukull WA; Kauppi K; McEvoy LK; Andreassen OA; Dale AM; Fan CC; Desikan RS Ann Neurol; 2017 Sep; 82(3):484-488. PubMed ID: 28940650 [TBL] [Abstract][Full Text] [Related]
9. Combining Polygenic Hazard Score With Volumetric MRI and Cognitive Measures Improves Prediction of Progression From Mild Cognitive Impairment to Alzheimer's Disease. Kauppi K; Fan CC; McEvoy LK; Holland D; Tan CH; Chen CH; Andreassen OA; Desikan RS; Dale AM; Front Neurosci; 2018; 12():260. PubMed ID: 29760643 [TBL] [Abstract][Full Text] [Related]
10. Polygenic Hazard Score Associated Multimodal Brain Networks Along the Alzheimer's Disease Continuum. Li K; Fu Z; Qi S; Luo X; Zeng Q; Xu X; Huang P; Zhang M; Calhoun VD Front Aging Neurosci; 2021; 13():725246. PubMed ID: 34539385 [TBL] [Abstract][Full Text] [Related]
11. The Association between Polygenic Hazard and Markers of Alzheimer's Disease Following Stratification for APOE Genotype. De Marco M; Manca R; Kirby J; Hautbergue GM; Blackburn DJ; Wharton SB; Venneri A; Alzheimer's Disease Neuroimaging Initiative Curr Alzheimer Res; 2020; 17(7):667-679. PubMed ID: 33023447 [TBL] [Abstract][Full Text] [Related]
12. Sex-dependent autosomal effects on clinical progression of Alzheimer's disease. Fan CC; Banks SJ; Thompson WK; Chen CH; McEvoy LK; Tan CH; Kukull W; Bennett DA; Farrer LA; Mayeux R; Schellenberg GD; Andreassen OA; Desikan R; Dale AM Brain; 2020 Jul; 143(7):2272-2280. PubMed ID: 32591829 [TBL] [Abstract][Full Text] [Related]
13. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study. Burnham SC; Bourgeat P; Doré V; Savage G; Brown B; Laws S; Maruff P; Salvado O; Ames D; Martins RN; Masters CL; Rowe CC; Villemagne VL; Lancet Neurol; 2016 Sep; 15(10):1044-53. PubMed ID: 27450471 [TBL] [Abstract][Full Text] [Related]
14. Cognitive Decline in Alzheimer's Disease: Limited Clinical Utility for GWAS or Polygenic Risk Scores in a Clinical Trial Setting. Euesden J; Gowrisankar S; Qu AX; Jean PS; Hughes AR; Pulford DJ Genes (Basel); 2020 May; 11(5):. PubMed ID: 32370229 [No Abstract] [Full Text] [Related]
15. Genetic Stratification to Identify Risk Groups for Alzheimer's Disease. Marioni RE; Campbell A; Hagenaars SP; Nagy R; Amador C; Hayward C; Porteous DJ; Visscher PM; Deary IJ J Alzheimers Dis; 2017; 57(1):275-283. PubMed ID: 28222519 [TBL] [Abstract][Full Text] [Related]
16. A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease. Porter T; Burnham SC; Savage G; Lim YY; Maruff P; Milicic L; Peretti M; Ames D; Masters CL; Martins RN; Rainey-Smith S; Rowe CC; Salvado O; Taddei K; Groth D; Verdile G; Villemagne VL; Laws SM Front Aging Neurosci; 2018; 10():423. PubMed ID: 30620773 [TBL] [Abstract][Full Text] [Related]
17. A comprehensive analysis of methods for assessing polygenic burden on Alzheimer's disease pathology and risk beyond Altmann A; Scelsi MA; Shoai M; de Silva E; Aksman LM; Cash DM; Hardy J; Schott JM Brain Commun; 2020; 2(1):fcz047. PubMed ID: 32226939 [TBL] [Abstract][Full Text] [Related]
18. Polygenic risk of Alzheimer disease is associated with early- and late-life processes. Mormino EC; Sperling RA; Holmes AJ; Buckner RL; De Jager PL; Smoller JW; Sabuncu MR; Neurology; 2016 Aug; 87(5):481-8. PubMed ID: 27385740 [TBL] [Abstract][Full Text] [Related]
20. The Differential Influence of Immune, Endocytotic, and Lipid Metabolism Genes on Amyloid Deposition and Neurodegeneration in Subjects at Risk of Alzheimer's Disease. Femminella GD; Harold D; Scott J; Williams J; Edison P; J Alzheimers Dis; 2021; 79(1):127-139. PubMed ID: 33216025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]